Delivery Order SPE2DX22D0019-SPE2D825FJS02

AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,383.12 by the Defense Logistics Agency's Medical Supply Chain on September 27, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-set-aside contract awarded through competitive procedures. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The award reflects AmerisourceBergen's established role as a critical federal vendor for pharmaceutical and medical supply procurement, with a demonstrated portfolio encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company supports various federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. As the DLA Troop Support pursues next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts, with plans for multiple regional awards involving several contractors, AmerisourceBergen's current contract demonstrates its continued capability to meet federal medical procurement requirements through open competition and flexible delivery mechanisms.